Patient‐physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer
Authors:
Open Access
Abstract
BACKGROUND.: Physician‐reported performance status (PS) is an important prognostic factor and frequently influences treatment decisions. To the authors' knowledge, the extent, prognostic importance, and predictors of disagreements in PS assessment between physicians and patients have not been adequately examined.METHODS.: Using North Central Cancer Treatment Group (NCCTG) clinical trial data from 1987 through 1990, the authors compared PS (Eastern Cooperative Oncology Group [ECOG] and Karnofsky [KPS]) and nutrition scores reported by physicians and patients individually. Differences were analyzed using a Student t test for paired data and degree of disagreement by kappa statistic. The effect of disagreement on overall survival was determined by the Kaplan‐Meier method and Cox regression analysis. Predictors of disagreement were identified by logistic regression.RESULTS.: In all, 1636 patients with advanced lung and colorectal cancer had a median survival of 9.8 months (95% confidence interval [95% CI], 9.4‐10.4 months). Percent disagreement between patients and physicians regarding KPS, ECOG PS, and nutrition score were 67.1%, 56.6%, and 58.0%, respectively. Physicians were more likely to rate patients better than individual patients were to rate themselves: ECOG (mean 0.91 vs 1.30; P < .0001), KPS (mean 83.3 vs 81.7; P < .0001), and nutrition score (mean 1.6 vs 2.1; P < .0001). Disagreement between patients and their physicians was associated with increased risk of death: KPS (hazards ratio [HR] of 1.16; 95% CI, 1.04‐1.30 [P = .008]) and nutrition scores (HR of 1.44; 95% CI, 1.29‐1.61 [P < .0001]) after adjustment for covariates. Patient sociodemographic factors that predict disagreement were identified.CONCLUSIONS.: Physicians and patients frequently disagree regarding PS and nutritional status. Disagreement is associated with an increased risk of death in patients with advanced malignancies. These findings illustrate the limitations of physician‐only assessed PS. Cancer 2008. © 2008 American Cancer Society.Keywords
This publication has 30 references indexed in Scilit:
- Whose Opinion Counts?Journal of Clinical Oncology, 2006
- How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30Journal of Clinical Oncology, 2004
- Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study Commentary: Why do doctors overestimate? Commentary: Prognoses should be based on proved indices not intuitionBMJ, 2000
- Successful Validation of the Palliative Prognostic Score in Terminally Ill Cancer PatientsJournal of Pain and Symptom Management, 1999
- Karnofsky and ECOG performance status scoring in lung cancer: A prospective, longitudinal study of 536 patients from a single institutionEuropean Journal of Cancer, 1996
- The interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovaryNutrition and Cancer, 1993
- Can Karnofsky performance status be transformed to the Eastern Cooperative Oncology Group scoring scale and vice versa?European Journal of Cancer, 1992
- Correlation of patient and caregiver ratings of cancer painJournal of Pain and Symptom Management, 1991
- Cancer patients' insight into their treatment, prognosis, and unconventional therapiesCancer, 1984
- Prognostic effect of weight loss prior tochemotherapy in cancer patientsThe American Journal of Medicine, 1980